SkinOther Lifting and Tightening

Oligio treatment

올리지오 · Korean term

Oligio is a radiofrequency (RF) skin-tightening device made by the Korean company Wontech, used without incisions to treat loose skin. One small study of the Oligio device in 30 adults with mild-to-moderate lower-face laxity reported gradual improvement and short-lived redness, but it had no comparison group, so the evidence is limited and results are not guaranteed.

On this page

Overview

AI-generated portrait of an adult East Asian woman in a consultation room.
AI-generated editorial illustration; not a patient result

Oligio is the brand name of a radiofrequency (RF) device used for skin tightening. U.S. Food and Drug Administration (FDA) records list Wontech Co., Ltd., based in Daejeon, South Korea, as the company behind a device called "The Oligio" [1] [2]. A separate FDA record exists for a model called Oligio X [3]. Different model names should not be assumed to be the same device or to share the same evidence, so ask the clinic which model it uses.

What it is

The U.S. device identifier database describes The Oligio as a radiofrequency therapy system and files it under the general category of RF skin and body contouring systems, which use RF energy to heat tissue beneath the skin [2]. A clinical study that used the Oligio device describes it as a monopolar RF device [5]. The goal is firmer-looking skin; this is an aim, not a guaranteed result.

What it involves

In the one study identified, 30 adults with mild-to-moderate sagging of the lower face had a single treatment session and were followed for six months [5]. Clinics may use different numbers of sessions, settings and treatment areas. These should be decided by the treating clinician after an assessment.

Reasons to discuss it with a clinician and limits

Treating loose skin for appearance is a cosmetic choice, so treatment is optional. A consultation is a chance to discuss your goals, the alternatives (including no treatment) and whether this device suits your skin.

The evidence is limited. In the Oligio study, two blinded dermatologists graded the results; most participants showed mild-to-moderate improvement that continued through the six months [5]. However, the study was small, had no comparison group (the authors list this as a limitation), and included only people with Fitzpatrick skin types III to V. The device was supplied by a distributor, and Wontech paid the journal's publication fees [5]. Results in a small group cannot predict one person's outcome.

Risks and considerations

In the study, most participants had skin redness right after treatment that faded within one to two days. One person reported facial dryness that had resolved by the three-month visit. No serious adverse events or complications were seen at three or six months, and participants rated treatment pain in the lower part of a 10-point scale on average [5]. This is a short-term report from 30 people, so less common or delayed problems may not have shown up. Ask the clinic what side effects it sees and how it protects the skin during heating.

Recovery and follow-up

The only short-term effects reported in the study were redness that settled within one to two days and one case of dryness [5]. The visits at one, three and six months were research measurement points, not recovery instructions. Aftercare advice, what changes to expect and when to seek help should come from the clinician who treats you.

Questions to ask

  • Which exact Oligio model do you use (for example, The Oligio or Oligio X)?
  • Is this model approved by Korea's Ministry of Food and Drug Safety for the use you are proposing?
  • What results are realistic for my skin, and how gradual are they?
  • What side effects do you see, and how is the skin protected from burns?
  • What alternatives, including no treatment, would you suggest for my goals?
  • Who will perform the treatment, and what follow-up is included?

Educational information. AI editorial and source checking are not clinical review. Checked 16 Nov 2026.

Category
Skin
General estimate
Not availableNo reviewed estimate exists. Clinic prices, when published, appear on each clinic profile.

Doctors who list oligio treatment

No doctors documented for this procedure yet.

A doctor appears here only when their scope is documented for this procedure at an exact clinic location.

Clinics that list oligio treatment

Offering evidence from each clinic’s own website. Availability and suitability need confirmation with the clinic.

No clinics list it yet.

Sources

Clinical references

  1. 510(k) Premarket Notification K221989: The Oligio · U.S. Food and Drug Administration · Checked 16 Nov 2026
  2. AccessGUDID device record: The Oligio (08800022305310) · U.S. National Library of Medicine / FDA (AccessGUDID) · Checked 16 Nov 2026
  3. 510(k) Premarket Notification K243929: Oligio X · U.S. Food and Drug Administration · Checked 16 Nov 2026
  4. Premarket Notification 510(k) · U.S. Food and Drug Administration · Checked 16 Nov 2026
  5. Efficacy and Safety of Monopolar Radiofrequency for Treatment of Lower Facial Laxity in Asians · Dermatology and Therapy (Springer), 2022; 12(11):2563-2573; DOI 10.1007/s13555-022-00817-8; full text via Europe PMC (PMC9588109) · Checked 16 Nov 2026
Catalogue source
Source

This page is for research. It is not medical advice and is not a recommendation. Whether a treatment suits you, its risks and its cost need an individual consultation with a licensed doctor.

Online correction reports are not open yet.